Effect of α-asarone and a derivative on lipids, bile flow and Na +/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat

Fundamental and Clinical Pharmacology

Volumn 21, Issue 1, 2007, Pages 81-88

  Garduño Siciliano, Leticia ^a   Labarrios, Fernando ^b   Tamariz, Joaquín ^b   Moreno, Mario G ^a   Chamorro, Germán ^a   Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Estrogens; Ethynylestradiol; K+ ATPase; Liver damage; Liver injury; N+

Indexed keywords

2 METHOXY 4 (2 PROPENYL)PHENOXYACETIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALKALINE PHOSPHATASE; ALPHA ASARONE; ANTILIPEMIC AGENT; BILE ACID; ETHINYLESTRADIOL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; CHOLESTASIS; CHOLESTEROL BILE LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; LIPID ANALYSIS; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ANIMALS; ANISOLES; ANTILIPEMIC AGENTS; BILE; CELL MEMBRANE; CHOLESTASIS; CHOLESTEROL; ESTROGENS; ETHINYL ESTRADIOL; HEPATOCYTES; MALE; NA(+)-K(+)-EXCHANGING ATPASE; PHENOXYACETATES; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 33846192354     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00453.x     Document Type: Article

References (39)

1. Trauner M., Meier P.J., Boyer J.L. Molecular pathogenesis of cholestasis. N. Engl. J. Med. (1998) 339 1217-1227.
2. Hagenbuch B., Meier P.J. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin. Liver Dis. (1996) 16 129-136.
3. Schreiber A., Simon F.R. Estrogen-induced cholestasis: clues to pathogenesis and treatment. Hepatology (1983) 3 607-613.
4. Rodríguez-Garay E.A. Cholestasis: human disease and experimental animal models. Ann. Hepatol. (2003) 2 150-158.
5. Enriquez R.G., Chávez M.A., Jáuregui F. Propenylbenzenes from Guatteria gaumeri. Phytochemistry (1980) 19 2024-2025.
6. Garduño L., Salazar M., Salazar S. et al. Hypolipidemic activity of α-asarone in mice. J. Etnopharmacol. (1997) 55 161-163.
7. Hernández A., López M.L., Chamorro G., Mendoza-Figueroa T. Inhibition of lipid synthesis and secretion in long-term cultures of adult rat hepatocytes by α-asarone. Planta Med. (1993) 59 121-124.
8. Cruz A., Garduño L., Salazar M. et al. Synthesis and hypolipidemic activity of modified side chain alpha-asarone homologues. Arzneimittelforschung (2001) 51 535-544.
9. Labarrios F., Garduño L., Vidal M.R. et al. Synthesis and hypolipidaemic evaluation of a series of a-asarone analogues related to clofibrate in mice. J. Pharm. Pharmacol. (1999) 51 1-7.
10. Bergmeyer H.U., Grabl M., Walter H.E. Enzymes, in: Bergmeyer J., Grabl M. (Eds), Methods of enzymatic analysis, Verlag-Chemie, Weinheim, Germany 1983, pp. 269-270.
11. Neville G.H., Jr. The isolation of a cell membrane fraction from rat liver. Biophys. Biochem. Cytol. (1960) 8 413-422.
12. Meier P.J., Sztul E.S., Reuben A., Boyer J.L. Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J. Cell Biol. (1984) 98 991-1000.
13. Wisher M.H., Evans W. Functional polarity of the rat hepatocyte surface membrane. Isolation and characterization of plasma-membrane subfractions from the blood-sinusoidal, bile-canalicular and contiguous surfaces of the hepatocyte. Biochem. J. (1975) 146 375-388.
14. +-ATPase activity. Nitric Oxide: Biol. Chem. (2000) 4 333-342.
15. Bossard R., Stieger B., O'Neill B., Fricker G., Meier P.J. Ethinylestradiol treatment induces multiple canalicular membrane transport alterations in rat liver. J. Clin. Invest. (1993) 91 2714-2720.
16. Muriel P., Mourelle M. The role of membrane composition in ATPase activities of cirrhotic rat liver: effect of silymarin. J. Appl. Toxicol. (1990) 10 281-284.
17. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. (1966) 8 115-118.
18. Dietmaier A., Gasser R., Graf J., Peterlik M. Investigations on the sodium dependence of bile acid fluxes in the isolated perfused rat liver. Biochim. Biophys. Acta (1976) 443 81-91.
19. Iga T., Klaassen C.D. Uptake of bile acids by isolated rat hepatocytes. Biochem. Pharmacol. (1982) 31 211-216.
20. Lee J., Trauner M., Soroka C.J., Stieger B., Meier P.J., Boyer J.L. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology (2000) 118 163-172.
21. Simon F.R., Fortune J., Iwahashi M., Gartung C., Wolkoff A., Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am. J. Physiol. (1996) 271 G1043-G1052.
22. Koopen N. R., Post S.M., Wolters H. et al. Differential effects of 17alpha-ethinylestradiol on the neutral and acidic pathways of bile salt synthesis in the rat. J. Lipid Res. (1999) 40 100-108.
23. Karpen S.J. Nuclear receptor regulation of hepatic function. J. Hepatol. (2002) 36 832-850.
24. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. (2003) 65 261-311.
25. Guo G., Lambert G., Negishi M. et al. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. (2003) 278 45062-45071.
26. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell (2000) 102 731-744.
27. Goodwin B., Jones S.A., Price R.R. et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell (2000) 6 517-526.
28. Lu T.T., Makishima M., Repa J.J. et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell (2000) 6 507-515.
29. Ananthanarayan M., Balasudramanian N., Makishima M., Mangelsdorf D.J., Suchy F.J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem. (2001) 276 28857-28865.
30. Yamamoto Y., Moore R., Hess H.A. et al. Estrogen receptor a mediates 17α-ethynylestradiol causing hepatotoxicity. J. Biol. Chem. (2006) 281 16625-16631.
31. Yahuaca P., Amaya A., Rojkind M., Mourelle M. Cryptic adenosine triphosphatase activities in plasma membranes of CCl4-cirrhotic rats. Its modulation by changes in cholesterol/phospholipids ratios. Lab. Invest. (1985) 53 541-545.
32. Handler J.S. Overview of epithelial polarity. Ann. Rev. Physiol. (1989) 51 729-740.
33. Fallon M.B., Anderson J.M., Boyer J.L., Intrahepatic cholestasis, in: Schiff L., Schiff E.R. (Eds), Diseases of the liver, J.B. Lippincott Co., Philadelphia, PA, 1993, pp. 343-361.
34. Erlinger S. Bile flow, in: Arias I.M., Boyer J.L., Fausto N., Jakoby W.B., Schachter D., Shafritz D.A. (Eds), The liver biology and pathobiology, Raven Press, New York, 1994, pp. 769-786.
35. Sippel C.J., Anantharayanan M., Suchy F.J. Isolation and characterization of the canalicular membrane bile acid transport protein of rat liver. Am. J. Physiol. (1990) 258 G728-G737.
36. Reyes H., Simon F.R. Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin. Liver Dis. (1993) 13 289-301.
37. Simon F.R., Fortune J., Iwahashi M., Gartung C., Wolkoff A., Sutherland E. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am. J. Physiol. Gastrointest. Liver Physiol. (1996) 271 G1043-G1052.
38. Azer S.A., Stacey N.H. Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: physiological basis and pathophysiological changes in cholestatic liver dysfunction. J. Gastroenterol. Hepatol. (1996) 11 396-407.
39. +-ATPase, membrane fluidity, and bile flow in rats with ethinyl estradiol-induced cholestasis. Hepatology (1983) 3 12-17.